| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Sp1_fam | 3.53e-07 | 10 | 122 | 4 | IPR030450 | |
| Domain | Cadherin_CS | 8.03e-05 | 109 | 122 | 6 | IPR020894 | |
| Domain | CADHERIN_1 | 9.81e-05 | 113 | 122 | 6 | PS00232 | |
| Domain | Cadherin | 9.81e-05 | 113 | 122 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.03e-04 | 114 | 122 | 6 | PS50268 | |
| Domain | - | 1.03e-04 | 114 | 122 | 6 | 2.60.40.60 | |
| Domain | CA | 1.08e-04 | 115 | 122 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.13e-04 | 116 | 122 | 6 | IPR015919 | |
| Domain | Cadherin | 1.25e-04 | 118 | 122 | 6 | IPR002126 | |
| Domain | ILWEQ_dom | 2.52e-04 | 4 | 122 | 2 | IPR002558 | |
| Domain | ILWEQ | 2.52e-04 | 4 | 122 | 2 | SM00307 | |
| Domain | ILWEQ | 2.52e-04 | 4 | 122 | 2 | PD011820 | |
| Domain | - | 2.52e-04 | 4 | 122 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 2.52e-04 | 4 | 122 | 2 | PF01608 | |
| Domain | I_LWEQ | 2.52e-04 | 4 | 122 | 2 | PS50945 | |
| Domain | Anaphylatoxin_comp_syst | 4.18e-04 | 5 | 122 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 4.18e-04 | 5 | 122 | 2 | IPR001840 | |
| Domain | - | 5.24e-04 | 57 | 122 | 4 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 5.60e-04 | 58 | 122 | 4 | IPR013088 | |
| Domain | MHC_I_3 | 6.24e-04 | 6 | 122 | 2 | PF16497 | |
| Domain | fn3 | 6.85e-04 | 162 | 122 | 6 | PF00041 | |
| Domain | HECT | 7.09e-04 | 27 | 122 | 3 | PF00632 | |
| Domain | HECTc | 7.09e-04 | 27 | 122 | 3 | SM00119 | |
| Domain | HECT_dom | 7.09e-04 | 27 | 122 | 3 | IPR000569 | |
| Domain | HECT | 7.09e-04 | 27 | 122 | 3 | PS50237 | |
| Domain | ANATO | 8.70e-04 | 7 | 122 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 8.70e-04 | 7 | 122 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 8.70e-04 | 7 | 122 | 2 | PS01177 | |
| Domain | ANATO | 8.70e-04 | 7 | 122 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 8.70e-04 | 7 | 122 | 2 | IPR000020 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.15e-03 | 8 | 122 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 1.15e-03 | 8 | 122 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.15e-03 | 8 | 122 | 2 | IPR019742 | |
| Domain | SNF2_N | 1.17e-03 | 32 | 122 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.17e-03 | 32 | 122 | 3 | PF00176 | |
| Domain | FN3 | 1.36e-03 | 185 | 122 | 6 | SM00060 | |
| Domain | A2M | 1.84e-03 | 10 | 122 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.84e-03 | 10 | 122 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.84e-03 | 10 | 122 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.84e-03 | 10 | 122 | 2 | PF07677 | |
| Domain | A2M_comp | 1.84e-03 | 10 | 122 | 2 | PF07678 | |
| Domain | A2M_N | 1.84e-03 | 10 | 122 | 2 | PF01835 | |
| Domain | A2M_N | 1.84e-03 | 10 | 122 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.84e-03 | 10 | 122 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.84e-03 | 10 | 122 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.84e-03 | 10 | 122 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.84e-03 | 10 | 122 | 2 | IPR001599 | |
| Domain | FN3 | 1.97e-03 | 199 | 122 | 6 | PS50853 | |
| Domain | FN3_dom | 2.52e-03 | 209 | 122 | 6 | IPR003961 | |
| Domain | WW | 3.58e-03 | 47 | 122 | 3 | PF00397 | |
| Domain | UBA | 3.58e-03 | 47 | 122 | 3 | PS50030 | |
| Domain | WW | 3.80e-03 | 48 | 122 | 3 | SM00456 | |
| Domain | Znf_GATA | 4.20e-03 | 15 | 122 | 2 | IPR000679 | |
| Domain | GATA | 4.20e-03 | 15 | 122 | 2 | PF00320 | |
| Domain | WW_DOMAIN_1 | 4.51e-03 | 51 | 122 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 4.51e-03 | 51 | 122 | 3 | PS50020 | |
| Domain | WW_dom | 4.76e-03 | 52 | 122 | 3 | IPR001202 | |
| Domain | GATA_ZN_FINGER_1 | 4.78e-03 | 16 | 122 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 4.78e-03 | 16 | 122 | 2 | PS50114 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF410 SP1 SP2 SP3 SP4 HIVEP2 ZSCAN4 TRPS1 ADNP2 POGZ FAM170A CTCF | 4.79e-03 | 775 | 122 | 12 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF410 SP1 SP2 SP3 SP4 HIVEP2 ZSCAN4 TRPS1 ADNP2 POGZ FAM170A CTCF | 4.88e-03 | 777 | 122 | 12 | PS00028 |
| Domain | C345C | 5.40e-03 | 17 | 122 | 2 | SM00643 | |
| Domain | Znf_C2H2-like | ZNF410 SP1 SP2 SP3 SP4 HIVEP2 ZSCAN4 TRPS1 ADNP2 POGZ FAM170A CTCF | 5.89e-03 | 796 | 122 | 12 | IPR015880 |
| Domain | Terpenoid_cyclase/PrenylTrfase | 6.05e-03 | 18 | 122 | 2 | IPR008930 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 2.30e-05 | 59 | 82 | 5 | MM15838 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 3.81e-05 | 159 | 82 | 7 | M39373 | |
| Pubmed | HIVEP2 FN1 CEP85L RBL2 TRPS1 ADNP2 ARFGEF2 MAGI3 POGZ HUWE1 ARMCX4 FAF1 STAT6 FAN1 TRIM66 PDZD8 ROBO1 TLN2 SNAP25 R3HDM1 TARBP1 SMURF2 SLX4 AGTPBP1 | 6.14e-11 | 1285 | 129 | 24 | 35914814 | |
| Pubmed | 1.81e-10 | 4 | 129 | 4 | 27889927 | ||
| Pubmed | 9.01e-10 | 5 | 129 | 4 | 10547281 | ||
| Pubmed | 2.69e-09 | 6 | 129 | 4 | 16201967 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP1 SP3 ARHGAP32 SP4 CRTC3 EP400 NUMA1 TSC22D2 LMTK3 NEDD4 ARHGAP6 LARP4B MAML2 | 8.47e-09 | 430 | 129 | 13 | 35044719 |
| Pubmed | SP1 SP2 ARHGAP32 GATAD2A EP400 SCAF8 TRPS1 NUMA1 PPP1R13B CHD8 POGZ ANKHD1 RFX1 MCRIP2 LARP4B FAT1 CTCF BANP EPDR1 R3HDM1 PCDH7 SLX4 | 1.45e-08 | 1429 | 129 | 22 | 35140242 | |
| Pubmed | USP36 GATAD2A EP400 PKP4 TRPS1 ADNP2 CHD8 POGZ ANKHD1 TRIM66 LARP4B FAT1 THRA CTCF CRNN SDF4 AGTPBP1 WDR62 NIN | 3.29e-08 | 1116 | 129 | 19 | 31753913 | |
| Pubmed | Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. | 4.99e-08 | 3 | 129 | 3 | 11532028 | |
| Pubmed | Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. | 4.99e-08 | 3 | 129 | 3 | 7559627 | |
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 23540600 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 26967243 | ||
| Pubmed | Curcumin decreases specificity protein expression in bladder cancer cells. | 4.99e-08 | 3 | 129 | 3 | 18593936 | |
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 21919647 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 26431879 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 25793500 | ||
| Pubmed | EP400 SCAF8 PYM1 ICE1 HUWE1 PLD3 SLC30A1 LARP4B BANP PDZD8 ROBO1 SDF4 R3HDM1 AGTPBP1 WDR62 | 1.01e-07 | 733 | 129 | 15 | 34672954 | |
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 15781457 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 15788387 | ||
| Pubmed | USP36 ARHGAP32 PKP4 TRPS1 PPP1R13B HUWE1 SLC30A1 FAN1 PTPRB CASKIN2 PDZD8 ROBO1 SDF4 SLC12A7 PCDH7 AGTPBP1 NIN | 3.70e-07 | 1049 | 129 | 17 | 27880917 | |
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 20538607 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 12560508 | ||
| Pubmed | USP36 EP400 PIEZO1 HIP1R CHD8 ICE1 POGZ ANKHD1 INTS2 CASKIN2 MAML2 NIN | 7.08e-07 | 529 | 129 | 12 | 14621295 | |
| Pubmed | Transcriptional regulation of P450scc gene expression in the embryonic rodent nervous system. | 9.89e-07 | 6 | 129 | 3 | 14576192 | |
| Pubmed | Differential intranuclear organization of transcription factors Sp1 and Sp3. | 9.89e-07 | 6 | 129 | 3 | 15987735 | |
| Pubmed | Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. | 9.89e-07 | 6 | 129 | 3 | 11773012 | |
| Pubmed | β-Sheet Augmentation Is a Conserved Mechanism of Priming HECT E3 Ligases for Ubiquitin Ligation. | 9.89e-07 | 6 | 129 | 3 | 29964046 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ZNF410 SP1 SP2 SP3 SP4 HIVEP2 TRPS1 ADNP2 TSC22D2 RFX1 AR STAT6 THRA CTCF UBP1 | 1.50e-06 | 908 | 129 | 15 | 19274049 |
| Pubmed | 1.73e-06 | 7 | 129 | 3 | 12004059 | ||
| Pubmed | Mammalian SP/KLF transcription factors: bring in the family. | 2.15e-06 | 25 | 129 | 4 | 15820306 | |
| Pubmed | FN1 ZSCAN4 ARFGEF2 PPP1R13B HUWE1 RFX1 FAF1 NEDD4 AP2A2 SDF4 KIF13A SMURF2 | 2.23e-06 | 591 | 129 | 12 | 15231748 | |
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 2.75e-06 | 8 | 129 | 3 | 10072631 | |
| Pubmed | EP400 SCAF8 POGZ NEDD4 SRGAP3 SEL1L3 ACIN1 MTCL1 R3HDM1 AGTPBP1 | 3.08e-06 | 407 | 129 | 10 | 12693553 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NACA2 HIVEP2 EP400 PIEZO1 HIP1R ARFGEF2 CHD8 ICE1 HUWE1 ANKHD1 FAT1 BANP PDZD8 TLN2 SDF4 SMURF2 | 3.58e-06 | 1105 | 129 | 16 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SP1 EP400 SCAF8 NUMA1 ARFGEF2 POGZ HUWE1 RFX1 ACIN1 TLN2 PCDH7 AGTPBP1 WDR62 | 6.55e-06 | 774 | 129 | 13 | 15302935 |
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 8.05e-06 | 11 | 129 | 3 | 10686478 | |
| Pubmed | NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation. | 1.07e-05 | 12 | 129 | 3 | 24107629 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | GATAD2A EP400 TRPS1 CHD8 POGZ HUWE1 RFX1 CTCF UBP1 BANP ACIN1 | 1.20e-05 | 583 | 129 | 11 | 29844126 |
| Pubmed | DPAGT1 FN1 PYM1 HUWE1 ANKHD1 TUB STAT6 LARP4B INTS2 UBP1 ACIN1 SDF4 EPDR1 KIF13A SLX4 | 1.26e-05 | 1084 | 129 | 15 | 11544199 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.37e-05 | 2 | 129 | 2 | 16565498 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15998580 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 19062096 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 10825178 | ||
| Pubmed | HPV8 activates cellular gene expression mainly through Sp1/3 binding sites. | 1.37e-05 | 2 | 129 | 2 | 31299490 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.37e-05 | 2 | 129 | 2 | 19933335 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 30055028 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.37e-05 | 2 | 129 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.37e-05 | 2 | 129 | 2 | 17645767 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12207352 | ||
| Pubmed | CTCF-dependent chromatin insulator is linked to epigenetic remodeling. | 1.37e-05 | 2 | 129 | 2 | 16949368 | |
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.37e-05 | 2 | 129 | 2 | 27758680 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 25538045 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22387014 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15864273 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.37e-05 | 2 | 129 | 2 | 23749435 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 23918728 | ||
| Pubmed | A novel fusion gene CRTC3-MAML2 in hidradenoma: histopathological significance. | 1.37e-05 | 2 | 129 | 2 | 29079171 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.37e-05 | 2 | 129 | 2 | 3037333 | |
| Pubmed | Regulation of androgen-responsive transcription by the chromatin remodeling factor CHD8. | 1.37e-05 | 2 | 129 | 2 | 20308527 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11726230 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.37e-05 | 2 | 129 | 2 | 6950384 | |
| Pubmed | Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors. | 1.37e-05 | 2 | 129 | 2 | 31164147 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.37e-05 | 2 | 129 | 2 | 8428773 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.37e-05 | 2 | 129 | 2 | 21345967 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 17681019 | ||
| Pubmed | Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice. | 1.37e-05 | 2 | 129 | 2 | 37735515 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 26807725 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 2572548 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 2302180 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15951564 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.37e-05 | 2 | 129 | 2 | 18091514 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 29080553 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 6589636 | ||
| Pubmed | Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. | 1.37e-05 | 2 | 129 | 2 | 22464952 | |
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.37e-05 | 2 | 129 | 2 | 25339671 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 17728371 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 6149580 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 6149581 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12115608 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 3542363 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 2387317 | ||
| Pubmed | Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. | 1.37e-05 | 2 | 129 | 2 | 8845379 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 10809237 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 16908004 | ||
| Pubmed | Substrate clustering potently regulates the activity of WW-HECT domain-containing ubiquitin ligases. | 1.37e-05 | 2 | 129 | 2 | 29463679 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 7365238 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 7391573 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 17971360 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.37e-05 | 2 | 129 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.37e-05 | 2 | 129 | 2 | 17971229 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 6881182 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 10642512 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.37e-05 | 2 | 129 | 2 | 17921792 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21880985 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21248046 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 1.37e-05 | 2 | 129 | 2 | 6978711 | |
| Interaction | FHL2 interactions | ZNF410 SP1 SP2 SP3 SP4 EP400 POGZ RFX1 AR LARP4B BANP SDF4 WDR62 | 1.23e-06 | 396 | 126 | 13 | int:FHL2 |
| Interaction | VEGFA interactions | 3.54e-06 | 66 | 126 | 6 | int:VEGFA | |
| Interaction | LOC254896 interactions | 7.02e-06 | 43 | 126 | 5 | int:LOC254896 | |
| Interaction | P4HA3 interactions | 7.04e-06 | 113 | 126 | 7 | int:P4HA3 | |
| Interaction | SP4 interactions | 9.85e-06 | 46 | 126 | 5 | int:SP4 | |
| Interaction | NKX3-1 interactions | 1.81e-05 | 52 | 126 | 5 | int:NKX3-1 | |
| Interaction | ZBTB7A interactions | 1.85e-05 | 131 | 126 | 7 | int:ZBTB7A | |
| Interaction | RHOQ interactions | ARHGAP32 PKP4 PLD3 SLC30A1 FAT1 AP2A2 CASKIN2 BANP PDZD8 ROBO1 SLC12A7 PCDH7 | 2.18e-05 | 442 | 126 | 12 | int:RHOQ |
| Interaction | POGZ interactions | 4.43e-05 | 265 | 126 | 9 | int:POGZ | |
| Interaction | CSGALNACT1 interactions | 5.01e-05 | 64 | 126 | 5 | int:CSGALNACT1 | |
| Interaction | VEGFB interactions | 5.84e-05 | 34 | 126 | 4 | int:VEGFB | |
| Interaction | RCOR1 interactions | SP1 GATAD2A TRPS1 NUMA1 CHD8 ICE1 HUWE1 ANKHD1 AR B9D2 TRIM66 WDR62 | 6.39e-05 | 494 | 126 | 12 | int:RCOR1 |
| Interaction | SMC1A interactions | EEF1AKMT3 NUMA1 HIP1R HUWE1 AR THRA CTCF ACIN1 SDF4 KIF13A SLX4 | 6.43e-05 | 418 | 126 | 11 | int:SMC1A |
| Interaction | OCLN interactions | ARHGAP32 PKP4 STYK1 PPP1R13B SLC30A1 NEDD4 CD1B CASKIN2 ROBO1 C4A SLC12A7 PCDH7 | 7.17e-05 | 500 | 126 | 12 | int:OCLN |
| Interaction | SUMO2 interactions | USP36 SP1 EP400 NUMA1 CHD8 POGZ HUWE1 LMTK3 AR NEDD4 LARP4B ACIN1 SLX4 | 8.58e-05 | 591 | 126 | 13 | int:SUMO2 |
| Interaction | ELK3 interactions | 1.08e-04 | 120 | 126 | 6 | int:ELK3 | |
| Interaction | ETS1 interactions | 1.13e-04 | 121 | 126 | 6 | int:ETS1 | |
| Interaction | ZFPL1 interactions | PKP4 ARFGEF2 PPP1R13B FAM170A SLC30A1 FAF1 VPS13D CASKIN2 ROBO1 SLC12A7 PCDH7 | 1.19e-04 | 448 | 126 | 11 | int:ZFPL1 |
| Interaction | ENO1 interactions | FN1 SCAF8 NUMA1 POGZ HUWE1 ANKHD1 AR FAF1 NEDD4 THRA LACTB2 PCDH7 SLX4 AGTPBP1 | 1.26e-04 | 701 | 126 | 14 | int:ENO1 |
| Interaction | BAG2 interactions | USP36 SP1 PSEN1 FN1 EEF1AKMT3 PPP1R13B HUWE1 ANKHD1 RFX1 TRIM66 VPS13D R3HDM1 WDR62 | 1.43e-04 | 622 | 126 | 13 | int:BAG2 |
| Interaction | MACROH2A1 interactions | 1.44e-04 | 458 | 126 | 11 | int:MACROH2A1 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 5.63e-08 | 9 | 85 | 4 | 755 | |
| GeneFamily | Fibronectin type III domain containing | 1.07e-04 | 160 | 85 | 6 | 555 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 7.70e-04 | 9 | 85 | 2 | 1234 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.68e-03 | 50 | 85 | 3 | 721 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.95e-03 | 718 | 85 | 10 | 28 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.20e-03 | 15 | 85 | 2 | 82 | |
| GeneFamily | Cadherin related | 2.84e-03 | 17 | 85 | 2 | 24 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.93e-03 | 20 | 85 | 2 | 548 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.64e-07 | 177 | 129 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.25e-06 | 187 | 129 | 7 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.34e-06 | 189 | 129 | 7 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 189 | 129 | 7 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 189 | 129 | 7 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 189 | 129 | 7 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|(1)_Control_(PBS) / Stress and Cell class | 1.49e-06 | 192 | 129 | 7 | 40f380f5f0bed63a7404be050838ebd01ef08987 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.59e-06 | 194 | 129 | 7 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 1.59e-06 | 194 | 129 | 7 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.59e-06 | 194 | 129 | 7 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.71e-06 | 196 | 129 | 7 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 196 | 129 | 7 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 197 | 129 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-06 | 200 | 129 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.04e-06 | 159 | 129 | 6 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.65e-06 | 168 | 129 | 6 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | droplet-Fat-Scat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 170 | 129 | 6 | de722bea7527d6ad11b69f8e9589638f52854beb | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-05 | 175 | 129 | 6 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 183 | 129 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 1.77e-05 | 187 | 129 | 6 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 1.77e-05 | 187 | 129 | 6 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 188 | 129 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 188 | 129 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-05 | 188 | 129 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.83e-05 | 188 | 129 | 6 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.88e-05 | 189 | 129 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.94e-05 | 190 | 129 | 6 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.94e-05 | 190 | 129 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.94e-05 | 190 | 129 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 191 | 129 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.00e-05 | 191 | 129 | 6 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.06e-05 | 192 | 129 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.06e-05 | 192 | 129 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.12e-05 | 193 | 129 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.12e-05 | 193 | 129 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.12e-05 | 193 | 129 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.12e-05 | 193 | 129 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.12e-05 | 193 | 129 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.18e-05 | 194 | 129 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 194 | 129 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.18e-05 | 194 | 129 | 6 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 195 | 129 | 6 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 195 | 129 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.24e-05 | 195 | 129 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-05 | 195 | 129 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.31e-05 | 196 | 129 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-05 | 196 | 129 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.44e-05 | 198 | 129 | 6 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.51e-05 | 199 | 129 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-05 | 200 | 129 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.14e-05 | 148 | 129 | 5 | 10dcbdb47cac908648d9d652c8095b536db19b8a | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.35e-05 | 153 | 129 | 5 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Endothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 9.05e-05 | 81 | 129 | 4 | a1193b2cfb84a6b6593779fef5f54a61567a12d7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-04 | 159 | 129 | 5 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 1.19e-04 | 165 | 129 | 5 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 1.19e-04 | 165 | 129 | 5 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.19e-04 | 165 | 129 | 5 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.23e-04 | 166 | 129 | 5 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.26e-04 | 167 | 129 | 5 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 170 | 129 | 5 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 172 | 129 | 5 | 9dca1542145d88559527db7e0f6ad150df59ca2d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 172 | 129 | 5 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 172 | 129 | 5 | 63a91974b12c3f7f0c6bf66c30088d7fc07f5cea | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 172 | 129 | 5 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 173 | 129 | 5 | a7dee23b1d43d3070d502487af319ff81a9a747b | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.61e-04 | 176 | 129 | 5 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 179 | 129 | 5 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-04 | 180 | 129 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | Endothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.79e-04 | 180 | 129 | 5 | 4c3376169770ee9f9283daae44c17f35e46bfd19 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 181 | 129 | 5 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 181 | 129 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 181 | 129 | 5 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.83e-04 | 181 | 129 | 5 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.88e-04 | 182 | 129 | 5 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-04 | 182 | 129 | 5 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-04 | 182 | 129 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 1.88e-04 | 182 | 129 | 5 | 310f94437d197eaaaf6e30e68063b33e94befe77 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.88e-04 | 182 | 129 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.93e-04 | 183 | 129 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-04 | 183 | 129 | 5 | 91079a11685dd466bd27a0cf5afbf3734c08a05e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-04 | 184 | 129 | 5 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 2.03e-04 | 185 | 129 | 5 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.03e-04 | 185 | 129 | 5 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-04 | 186 | 129 | 5 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 186 | 129 | 5 | b9fb7210f615faff0633a1c82dd3be38cb72a00b | |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 2.08e-04 | 186 | 129 | 5 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-04 | 186 | 129 | 5 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.08e-04 | 186 | 129 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.13e-04 | 187 | 129 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.13e-04 | 187 | 129 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.13e-04 | 187 | 129 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 188 | 129 | 5 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 188 | 129 | 5 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.19e-04 | 188 | 129 | 5 | aa516273cdde53c8c0295f06830972388f890c97 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-04 | 188 | 129 | 5 | a37edd8f9e4a4e336b5acbb0407d3d275975cee8 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.24e-04 | 189 | 129 | 5 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-04 | 189 | 129 | 5 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.30e-04 | 190 | 129 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.30e-04 | 190 | 129 | 5 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 190 | 129 | 5 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| Drug | SP 0 | 1.95e-07 | 10 | 128 | 4 | CID002742752 | |
| Drug | Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.93e-06 | 199 | 128 | 9 | 6155_UP | |
| Drug | AC1L1B35 | 3.80e-06 | 74 | 128 | 6 | CID000001263 | |
| Drug | ADP-ribosylarginine | 1.10e-05 | 25 | 128 | 4 | CID000126311 | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; HL60; HT_HG-U133A | 1.49e-05 | 195 | 128 | 8 | 2189_UP | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.61e-05 | 197 | 128 | 8 | 1470_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 1.67e-05 | 198 | 128 | 8 | 4282_DN | |
| Disease | allergic sensitization measurement | 1.37e-04 | 62 | 124 | 4 | EFO_0005298 | |
| Disease | reticulocyte measurement | SP1 PSEN1 GATAD2A PIEZO1 TRPS1 ARFGEF2 TSC22D2 AR F10 FAF1 LARP4B FAT1 TLN2 SLC12A7 | 1.42e-04 | 1053 | 124 | 14 | EFO_0010700 |
| Disease | schizophrenia (implicated_via_orthology) | 1.97e-04 | 68 | 124 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | EFCAB5 HIVEP2 SCAF8 TRPS1 FAF1 SPTBN5 FCGBP CTCF SRGAP3 IL1RL1 MTCL1 MAML2 KIF13A TNXB SMURF2 | 2.04e-04 | 1228 | 124 | 15 | EFO_0004713 |
| Disease | PR interval | EFCAB5 CEP85L EMILIN2 TSC22D2 FAF1 GJA5 FAT1 CASKIN2 SLC12A7 | 2.53e-04 | 495 | 124 | 9 | EFO_0004462 |
| Disease | intellectual disability (implicated_via_orthology) | 2.87e-04 | 75 | 124 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | joint hypermobility measurement | 3.60e-04 | 33 | 124 | 3 | EFO_0007905 | |
| Disease | beta-defensin 119 measurement | 4.82e-04 | 8 | 124 | 2 | EFO_0801419 | |
| Disease | mean reticulocyte volume | DPAGT1 SP1 SP3 NACA2 GATAD2A EP400 PIEZO1 FAF1 FANCG TLN2 SLC12A7 | 5.66e-04 | 799 | 124 | 11 | EFO_0010701 |
| Disease | Headache, glucose measurement | 6.19e-04 | 9 | 124 | 2 | EFO_0004468, HP_0002315 | |
| Disease | osteoarthritis, hip | 6.24e-04 | 92 | 124 | 4 | EFO_1000786 | |
| Disease | renal cell carcinoma | 7.38e-04 | 42 | 124 | 3 | EFO_0000681 | |
| Disease | Malignant Head and Neck Neoplasm | 8.46e-04 | 44 | 124 | 3 | C0278996 | |
| Disease | Macrocephaly | 9.40e-04 | 11 | 124 | 2 | C0221355 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 1.09e-03 | 48 | 124 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | red blood cell density measurement | SP1 SP3 SP4 EP400 PIEZO1 PKP4 TRPS1 ARFGEF2 GJA5 LARP4B MAML2 | 1.24e-03 | 880 | 124 | 11 | EFO_0007978 |
| Disease | Fanconi anemia | 1.54e-03 | 14 | 124 | 2 | cv:C0015625 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 2.02e-03 | 16 | 124 | 2 | C0751885 | |
| Disease | hypertension (implicated_via_orthology) | 2.12e-03 | 128 | 124 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | USP36 GATAD2A FN1 TRPS1 CELA2A POGZ TSC22D2 FAF1 B9D2 TRIM66 RASL11A TLN2 MAP4K2 NIN | 2.17e-03 | 1392 | 124 | 14 | EFO_0005763 |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 2.29e-03 | 17 | 124 | 2 | C0751883 | |
| Disease | chronic obstructive pulmonary disease | 2.55e-03 | 688 | 124 | 9 | EFO_0000341 | |
| Disease | Bone marrow hypocellularity | 2.56e-03 | 18 | 124 | 2 | C1855710 | |
| Disease | cortical thickness | SP1 GATAD2A TRPS1 ARFGEF2 TSC22D2 FAF1 VPS13D SRGAP3 ROBO1 MTCL1 KIF13A PCDH7 | 2.58e-03 | 1113 | 124 | 12 | EFO_0004840 |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 2.86e-03 | 19 | 124 | 2 | C0751884 | |
| Disease | Intellectual Disability | 2.88e-03 | 447 | 124 | 7 | C3714756 | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.10e-03 | 69 | 124 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | diverticular disease | 3.27e-03 | 236 | 124 | 5 | EFO_0009959 | |
| Disease | mean platelet volume | ARHGAP32 HIVEP2 PCDHGC5 PCDHGA9 NUMA1 HIP1R TSC22D2 FANCG MAML2 SLC12A7 NIN | 3.88e-03 | 1020 | 124 | 11 | EFO_0004584 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.94e-03 | 152 | 124 | 4 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QASLVEEGQPQTRQE | 6 | Q99569 | |
| VTQVVPAEGQENGQR | 921 | Q9UKV3 | |
| PQGEQVQITQDSEGN | 401 | Q8N9N5 | |
| LQSVGPVVGGNQQIT | 76 | Q96L91 | |
| QYSIGGPQEQITVQE | 136 | Q9UM22 | |
| QNTDRGTVQGQLQGP | 41 | P07311 | |
| SVIDGDEAQVTQQPG | 1721 | Q9HCK8 | |
| LPVGTVENQQGQDID | 261 | Q9BRK5 | |
| QPTAIIQVEDQNTGA | 666 | P49711 | |
| IQQNTDGSGQVSIPI | 421 | P0C0L5 | |
| FQGPQTDEGVQLQII | 126 | Q9Y6D5 | |
| QQQIGPRLGTEEQGT | 871 | Q8IYW2 | |
| VQANVPAGGQAQVRA | 116 | Q96AZ1 | |
| GRLQTNGAVPDVLQQ | 161 | P08217 | |
| GEQEQQGTQLGDILP | 241 | P29016 | |
| DRTLQQQPGDQNRTI | 506 | Q9UPW5 | |
| GSVQPQIVANSQGEV | 706 | Q5H9R4 | |
| PTENSEQGGRQTQEQ | 86 | Q96KQ4 | |
| QGVNSGVLQLSQPVV | 536 | Q6IQ32 | |
| PTVEGGAQVQQVVNI | 776 | O94973 | |
| GQPNSIGNQIQGVVI | 711 | Q15032 | |
| DGQTPISQRQQIVDG | 691 | Q9Y620 | |
| QGEGDQQEPQLLGTI | 861 | Q9Y4B5 | |
| PGSAQQVIQVDRDTI | 701 | Q12851 | |
| QTVTIPVQGIANENG | 741 | Q08999 | |
| PVQVNVGGQAQAVTG | 761 | Q08999 | |
| GTTLQVPGQVAIQQI | 796 | Q08999 | |
| VPSVQIQGQRIIQQG | 276 | Q86YP4 | |
| PGIVSVQSIQVNDGQ | 3896 | Q14517 | |
| TQEPSAQQGEEVLRQ | 136 | Q8IV08 | |
| QQGLPQGDTQLTTVQ | 26 | Q8WUE5 | |
| QINVVGRTVPASVQG | 986 | P23467 | |
| DQIVEINGEPTQGIT | 1066 | Q5TCQ9 | |
| DSGQQVTQPSEIEQG | 826 | P46934 | |
| GVQSQVQLVQSGAEV | 16 | P01742 | |
| INGVRSPQTRQAGQT | 446 | Q92615 | |
| LPVNGVTVLENGDQR | 921 | Q96Q04 | |
| EQEQQGTQRGDILPS | 241 | P06126 | |
| QLQPQESGRAEQGSQ | 871 | Q5VYM1 | |
| RQQIPESQGVISGAV | 51 | Q9H3H5 | |
| VSVNIQVGDVNDNRP | 2781 | Q9NYQ8 | |
| RNPQREEIIGNGEQQ | 106 | Q53H82 | |
| NVQTGDNGAINPELV | 181 | Q9Y5G4 | |
| TQQVVVLVRDNGDPS | 641 | Q9Y5F6 | |
| RLVVQVNDSGQPSQS | 816 | O60245 | |
| ERPVGQSNQGAVLQD | 446 | Q8NEN9 | |
| QDRPSQNNTIGLVGQ | 901 | Q9H0H0 | |
| QNNTIGLVGQTDAPE | 906 | Q9H0H0 | |
| ETSPRQQQQQQGEDG | 81 | P10275 | |
| TQEQQGPRLEQGLRE | 106 | O15287 | |
| ELQQRIQAGEVSQPS | 166 | Q9BRP8 | |
| QDENRVPSGVNVEGA | 406 | Q8IVL5 | |
| QAVQISGLDPNGEQV | 186 | Q9HBH1 | |
| SQRSAEQPPVVGQVQ | 1311 | A7KAX9 | |
| GVQSQVQLVQSGAEV | 16 | A0A0B4J2H0 | |
| QEEGGSRREPQVNQQ | 1306 | Q7Z6Z7 | |
| QERISPQIQLSGQTE | 176 | Q9UBG3 | |
| TGTVGPGQAQQRLEQ | 1136 | Q8WXE0 | |
| TPTDQGGQAAEREQQ | 906 | O43182 | |
| QRQDQHSVVGQNTGP | 711 | Q8IZL2 | |
| PEQQRGVTAEQGPQR | 506 | A4FU69 | |
| REQQRSSQEQGELQG | 586 | O75146 | |
| FGEPRIQQEEGQNQS | 261 | Q01638 | |
| AVQGDGQKQRQPQAT | 976 | Q9Y2F5 | |
| PGGNRITQVQEDITN | 176 | Q5T0U0 | |
| GQVVSLAQGQQVTVD | 4916 | Q9Y6R7 | |
| TPTNGQQGNSLEEVV | 1211 | P02751 | |
| QVPLVQQGSRELQDS | 516 | Q6UUV7 | |
| SQQRQNGPGQRVIRE | 81 | Q9H6D8 | |
| NGPGQRVIREVNTTT | 86 | Q9H6D8 | |
| LVTEQVRGQEQTPGE | 296 | P36382 | |
| VRGQEQTPGEGFIQV | 301 | P36382 | |
| GAIQAQQQEVISPDT | 16 | P12110 | |
| LDQGQEPDQSRQQTV | 686 | Q5SZL2 | |
| LVAQRRTGPTQQQVE | 11 | Q9BUT9 | |
| QNLIVSNTEGPGEEV | 731 | Q08554 | |
| EVQEVGTQGSPVEVQ | 161 | Q587J8 | |
| PVEVQEAGTQQSLQA | 171 | Q587J8 | |
| EGQLRQLQEAAQGPT | 291 | Q9BXX0 | |
| INGVIPQENGILQSE | 41 | Q9UNN5 | |
| QVQRCQEVGGTPGTQ | 156 | Q8N9H9 | |
| NQTQPERGDNNLTRI | 221 | P00742 | |
| LSGVREGQTQVDTPQ | 36 | Q9BPU9 | |
| FIQNNVTEIQGIPGA | 356 | Q9Y666 | |
| RKGDNVPQVNGENTE | 1206 | Q9UPN6 | |
| IQQLEEVLSPTGRQG | 71 | P0C7I6 | |
| IQFGVGERPQAQENV | 826 | P20273 | |
| IQQNTDGSGQVSIPI | 421 | P0C0L4 | |
| QPIQIAEGTGITTRQ | 1971 | Q14980 | |
| QGQEAQTELPQARIS | 21 | P05451 | |
| TSQDIQLFGIGIQPQ | 476 | Q9H1H9 | |
| QVDPGQVGLINSNVS | 71 | Q9Y2M0 | |
| SLQIQDTPGGVQIQD | 76 | Q6T310 | |
| ATGQQQIIIDPSQGL | 66 | Q02446 | |
| GQQTSDQEVQPGKRL | 606 | Q02446 | |
| QALQQTGIVGGQEAP | 31 | Q9BZJ3 | |
| TVPRNQNESVSEIGG | 521 | Q68CR1 | |
| SNGRPQGNSRQVVEQ | 51 | P49768 | |
| QTQTQPLVGQVDDTR | 581 | O75157 | |
| ETNTPQGNQEQLVTV | 2021 | Q8N4C6 | |
| SQTGVPTQVVQQVQG | 126 | P22670 | |
| EGGVSINHQQVTNPE | 431 | Q9Y2Z4 | |
| GIVLNVQQGQTVRPI | 171 | Q7Z3K3 | |
| RQVGETVNLQIPFQG | 186 | Q13203 | |
| VQQDGSGQIQIIPGA | 196 | P08047 | |
| GDQGQVVIQLPGRVQ | 316 | Q9NPE6 | |
| GVIRVSPQERSQQNQ | 51 | Q7Z2R9 | |
| SQEVPNTLRVLGQQG | 1176 | Q9NRC6 | |
| PVLRETAQNTQTGNQ | 151 | Q8IY92 | |
| GNNQDGVVASQPARV | 106 | P60880 | |
| GNQQIVGQPQIAITG | 956 | Q8IWZ3 | |
| QPTQVSEQEIQGQEL | 286 | Q9UBN6 | |
| GPNDNDTVRGQIVVS | 121 | Q9HAU4 | |
| EQRTQQQRSGPQGIA | 51 | Q6J9G0 | |
| QQRGSNEEQVNGSPL | 966 | Q9UHF7 | |
| QQQGIFRVPGSQVEV | 536 | O43295 | |
| INGVQVQGVPVTITN | 441 | Q02086 | |
| GINQESSQIQIIPGS | 196 | Q02447 | |
| VIRGQDGSPQIENIQ | 576 | P42226 | |
| NVGPDGEETRAQTVQ | 81 | Q86VK4 | |
| GEPQSVQVDGQARTQ | 3796 | P22105 | |
| QPQSPLAQVQERGET | 81 | A1A519 | |
| VIRQGPVNQTVAVDG | 456 | Q9Y6N7 | |
| QQSQGPAVQREEGIS | 26 | Q8NAM6 | |
| RVLVSSGQVDTGQQQ | 1431 | O43379 | |
| GEQIQPSATIQETQQ | 361 | Q9NZI7 | |
| REQPSSTVLQGQQQA | 436 | Q9NZI7 | |
| PQLVQGVRGSQAQAE | 966 | Q9Y4G6 | |
| EPRQQVSQGTYGQEV | 136 | Q6R2W3 | |
| PQVRQLEQQLGEAGS | 411 | P10827 | |
| QEQARQEQAGQLPTG | 1466 | Q92508 | |
| SGQEPTVGSQIQRVV | 796 | Q13395 | |
| NPRSGDTVEVQVNGN | 211 | Q9Y6M5 | |
| RQPQIEPEQIGNTAS | 46 | P31629 | |
| PPVEQESTSQRLGQQ | 391 | O15016 | |
| EAQGPVQILTVGQSD | 146 | P50607 | |
| RRQEDGTQPQVNGQQ | 886 | Q9P275 | |
| LEQQEVPEGRTQGTL | 1176 | Q5TIE3 | |
| QQTPEGNVVEGLSAE | 446 | Q5THJ4 | |
| QGEAVGNIQENTQTP | 146 | Q9H009 | |
| GNIQENTQTPTVQEE | 151 | Q9H009 |